Abstract

A trial of antiadrenergic and antiseretonergic drugs in the treatment of 24 newly diagnosed and previously untreated infantile spasm patients is reported from the Epilepsy Research Center, Section of Neurophysiology, Department of Neurology, Baylor College of Medicine; the Methodist Hospital; and Texas Children’s Hospital; Houston, TX.

Highlights

  • Factors related by multivariate analysis to relapse were neurologic abnormalities and organic etiology, mental retardation, seizure type, and appearance or persistence of EEG abnoimalities during the course of the illness and before discontinuation of the drugs

  • The authors believe that drug withdrawal can be attempted In" patients with well controlled idiopathic epilepsy, without signs of brain damage and without persistent EEG

  • A trial oT antiadrenergic and antiseretonergic drugs in the treatment of 24 newly diagnosed and previously untreated infantile spasm patients is reported from the Epilepsy Research Center, Section of Neurophysiology, Department of Neurology, Baylor College of Medicine; the Methodist Hospital; and Texas Children's Hospital; Houston, TX

Read more

Summary

Introduction

Factors related by multivariate analysis to relapse were neurologic abnormalities and organic etiology, mental retardation, seizure type (infantile spasms, absence seizures), and appearance or persistence of EEG abnoimalities during the course of the illness and before discontinuation of the drugs. (Matricardi M et al Outcome after discontinuation of antiepileptic drug therapy in children with epilepsy. The authors believe that drug withdrawal can be attempted In" patients with well controlled idiopathic epilepsy, without signs of brain damage and without persistent EEG They stress that predictive factors must be considered to individualize the risk of relapse for each patient.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.